Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
7 results
Active substance : rituximab
Topics : Diseases and conditions
OK
Chercher
Filter
Topic
Diseases and conditions
(7)
Plus ...
Immune system diseases
(4)
Plus ...
Autoimmune diseases
(2)
Immune system diseases - miscellaneous
(1)
Immunologic deficiency syndromes
(1)
Infectious diseases
(3)
Plus ...
Virus diseases
(2)
Parasitic diseases and mycoses
(1)
Blood and lymphatic diseases
(3)
Plus ...
Hematologic cancers
(2)
Lymphatic diseases
(1)
Bone marrow diseases
(1)
Anemia and hemoglobinopathies
(1)
Congenital, genetic and rare diseases
(2)
Musculoskeletal diseases
(2)
Plus ...
Joint and rheumatic diseases
(2)
Respiratory tract diseases
(1)
Plus ...
Pulmonary and pleural diseases
(1)
Nervous system diseases
(1)
Plus ...
Central nervous system diseases
(1)
Skin and connective tissue diseases
(1)
Cancers - miscellaneous
(1)
Vascular diseases
(1)
Plus ...
Vascular diseases - miscellaneous
(1)
Diagnostic and therapeutic techniques
(5)
Plus ...
Diagnostic techniques and procedures
(3)
Plus ...
Biology (laboratory tests)
(3)
Drug therapy
(2)
Transfusions, transplantations
(1)
Economics and public health
(2)
Plus ...
Organisation of care
(1)
Health economics
(1)
Population groups
(1)
Plus ...
Paediatrics
(1)
Content type
Drugs, devices and medical acts
(4)
Plus ...
Health technology assessment
(3)
Medicine
(1)
Practice Guidelines and Other Guides
(3)
Plus ...
Practice guidelines
(2)
Chronic disease guide
(1)
Date
Last five years
(2)
Manufacturer
inconnu
(1)
industriels
(1)
Language
Français
(7)
Active substance
abatacept
(1)
aciclovir
(1)
acide folique
(1)
adalimumab
(1)
alcool
(1)
alemtuzumab
(3)
allopurinol
(1)
amoxicilline
(1)
atovaquone
(2)
azathioprine
(3)
busulfan
(1)
carbimazole
(1)
chloroquine
(1)
chlorpropamide
(1)
chlorure de sodium
(1)
ciclosporine
(3)
ciprofloxacine
(2)
cisplatine
(1)
cyclophosphamide
(3)
cytarabine
(1)
danazol
(1)
dapsone
(1)
eltrombopag
(1)
fer
(2)
fibronectine
(1)
ganciclovir
(1)
gemcitabine
(1)
ifosfamide
(1)
infliximab
(1)
itraconazole
(1)
leucine
(1)
oxaliplatine
(1)
paclitaxel
(1)
pentostatine
(1)
phosphate
(1)
piroxicam
(1)
posaconazole
(1)
prednisolone
(1)
prednisone
(2)
rifampicine
(1)
rituximab
(7)
romiplostim
(1)
sirolimus
(1)
sulfasalazine
(2)
tacrolimus
(1)
trastuzumab
(1)
valaciclovir
(1)
voriconazole
(1)
More filter
Save your search
Practice guidelines and other guides
- 3 results
Acquired and inherited aplastic anemia
Chronic disease guide
- Posted on 4/5/2024
Download
guide
Add to
my selection
Rheumatoid arthritis: management of established RA
Practice guidelines
- Posted on 27/5/2009
Add to
my selection
Patient selection criteria for at-home cancer chemotherapy
Practice guidelines
- Posted on 1/9/2003 - Mis à jour le 30/10/2006
Download
abstract
Add to
my selection
Drugs, devices and medical acts
- 4 results
MABTHERA
Medicine
- Posted on 27/4/2023
Add to
my selection
Assessment of biological tests for Pneumocystis Pneumonia (Pneumocystis jirovecii infections) diagnosis - INAHTA Brief
Health technology assessment
- Posted on 18/10/2017
Download
document
Add to
my selection
Laboratory examinations to test for Epstein-Barr virus as part of post-transplant lymphoproliferative disorder
Health technology assessment
- Posted on 20/11/2015
Download
document
Add to
my selection
See 4 result in Drugs, devices and medical acts
Français
English
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
m9a4a6VV7ab7Zyev